Compounds > bromodeoxyuridine
Page last updated: 2024-08-17

bromodeoxyuridine and Cancer of Prostate

bromodeoxyuridine has been researched along with Cancer of Prostate in 63 studies

Research

Studies (63)

TimeframeStudies, this research(%)All Research%
pre-19904 (6.35)18.7374
1990's24 (38.10)18.2507
2000's29 (46.03)29.6817
2010's4 (6.35)24.3611
2020's2 (3.17)2.80

Authors

AuthorsStudies
Hooper, JD; Kularathna, PK; Mackie, EJ; Pagel, CN; Sanaei, R; Young, ND1
Bergh, A; Halin Bergström, S; Lundholm, M; Nordstrand, A1
Abel, G; Barthelmes, J; Dueregger, A; Guggenberger, F; Haunschild, J; Intelmann, D; Klocker, H; Ramoner, R; Sampson, N; Schuh, M; Stecher, G1
Lewinska, A; Rzeszutek, I; Siwak, J; Wnuk, M1
Fernández-Martínez, AB; Lucio-Cazaña, J1
Febbo, PG; Finn, S; Fiore, C; Fiorentino, M; Fornari, A; Grisanzio, C; Hahn, WC; Inazuka, F; Kung, AL; Loda, M; Ma, J; Migita, T; Mucci, L; Palescandolo, E; Priolo, C; Ruiz, S; Shin, E; Signoretti, S; Stampfer, M; Subramanian, A; Xie, W; Zadra, G1
Estes, N; Knost, JA; Pulukuri, SM; Rao, JS1
Chen, NG; Donat, U; Gentschev, I; Härtl, B; Hess, M; Stritzker, J; Sturm, JB; Szalay, AA; Weibel, S1
Agarwal, C; Agarwal, R; Bhatia, N; Bosland, MC; Condon, MS; Tyagi, A1
Knudsen, KE; Monk, KR; Petre, CE; Puga, A; Wetherill, YB1
Dong, Y; Ganther, HE; Hawthorn, L; Ip, C; Zhang, H1
Fu, VX; Jarrard, DF; Schwarze, SR1
Bosland, MC; Condon, MS; Narayanan, BA; Narayanan, NK; Reddy, BS1
Benimetskaya, L; Lai, JC; Miller, PS; Santella, RM; Stein, CA; Wang, Q1
Chiao, JW; Chung, FL; Conaway, CC; Liu, D; Ramaswamy, G; Wang, L; Wu, H1
Brockhoff, G; Diermeier, S; Kubbies, M; Kunz-Schughart, LA; Schmidt-Bruecken, E1
Friel, CJ; Hanson, RH; Ho, SM; L'Esperance, JO; Mobley, JA; Wu, M1
Alley, MC; Dasmahapatra, GP; Didolkar, P; Ghosh, S; Roy, KK; Sausville, EA1
Hantz, HL; Martin, KR; Young, LF1
Campa, J; Carlin, S; Humm, JL; Larson, SM; Ling, CC; Pugachev, A; Ruan, S1
Carey, AM; Martin, FL; Morris, JD; Muir, GH; Pramanik, R; Ragavan, N; Zhang, X1
Garcia, AJ; Lawson, DA; Wang, S; Witte, ON; Wu, H; Wu, M1
Hlobilková, A; Malíková, J; Ulrichová, J; Zdarilová, A1
Barber, JA; Barber, NJ; Martin, FL; Morris, JD; Muir, GH; Pramanik, R; Zhang, X; Zhu, G1
Bemis, DL; Buttyan, R; Capodice, JL; Gorroochurn, P; Katz, AE1
Barrera, J; Cao, KH; Comstock, CE; Hess-Wilson, JK; Knudsen, ES; Knudsen, KE; Morey, LM; Sharma, A1
Hu, H; Jiang, C; Kim, SH; Lee, HJ; Li, G; Lü, J; Wang, Z1
Agarwal, C; Agarwal, R; Kaur, M; Roy, S; Sclafani, RA; Tecklenburg, M1
Durham, LE; Gray, DR; Greenberg, NM; Huss, WJ; Johnson, MA; Marmillion, ME; Smith, GJ; Tavakoli, K1
Dong, Y; Liu, S; Zhang, H; Zhao, L; Zhu, L1
Noordzij, MA; Oomen, MH; Schröder, FH; van der Kwast, TH; van Steenbrugge, GJ; van Weerden, WM1
Chen, TH; Coffey, DS; Pasternack, GR; Walensky, LD; Wu, TC1
Frizelle, SP; Limas, C1
Carroll, PR; Cher, ML; Chew, K; Rosenau, W1
Bentzen, SM; Høyer, M; Overgaard, J; Salling, LN1
Carroll, PR; Cohen, MB; Fong, P; Mayall, BH; Narayan, P; Rosenau, W; Vapnek, JM; Waldman, FM1
Flentje, M; Hahn, EW; Lohr, F; Peschke, P; Wenz, F1
de Jong, FH; Moerings, EP; Schröder, FH; van Kreuningen, A; van Steenbrugge, GJ; van Weerden, WM1
Høyer, M; Overgaard, J; Salling, LN1
Beekhuis, JA; Dohle, GR; Schröder, FH; Tanke, HJ; van Steenbrugge, GJ1
Fujimitsu, Y; Inada, K; Kobayashi, K; Nakanishi, H; Shirai, T; Tatematsu, M; Yamachika, T1
Austenfeld, MA; Mebust, WK; Noble, MJ; Rayford, W; Shah, GV; Weigel, J1
Ito, N; Kawabe, M; Sano, M; Shibata, MA; Shirai, T; Takesada, Y; Tamano, S1
Baisch, H; Fack, H; Otto, U1
Friedrich, E; Hahn, EW; Klein, V; Peschke, P; Wolber, G1
El-Deiry, WS; Mitchell, KO1
Ballangrud, AM; Dnistrian, A; Lampen, NM; Sgouros, G; Yang, WH1
de Jong, JM; Engelen, JJ; Kleinjans, JC; Schilderman, PA; Welle, IJ; Zwingmann, IH1
Fribourg, AF; Knudsen, ES; Knudsen, KE; Lindhorst, CM; Strobeck, MW1
Meistrich, ML; Pollack, A; Terry, NH; White, RA1
Guan, J; Kung, HJ; Lee, LF; Qiu, Y1
Cox, ME; Deeble, PD; Murphy, DJ; Parsons, SJ1
Bucana, CD; Davies, MA; Dong, Z; Gallick, GE; Kim, SJ; Parikh, NU1
Arya, SK; Carter, WA; Chawda, R; Horoszewicz, JS; Job, L1
Munzenrider, JE1
de Jong, FH; Elissen, NM; Schröder, FH; van Kreuningen, A; van Steenbrugge, GJ; van Weerden, WM1
Brinkmann, AO; Faber, PW; Ruizeveld de Winter, JA; Trapman, J; van der Kwast, TH; van Steenbrugge, GJ; van Weerden, WM1
Harada, M; Nakamura, Y; Nemoto, R; Shimizu, A1
Coptcoat, M; Rew, DA; Thomas, DJ; Wilson, GD1
Fathman, A; Meyer, JS; Rujanavech, N; Scrivner, DL; Scully, T1
Harada, M; Hattori, K; Koiso, K; Nemoto, R; Nishijima, Y; Shimazui, T; Uchida, K1
Harada, M; Hattori, K; Koiso, K; Nemoto, R; Shimazui, T; Uchida, K1
Gittes, RF; Sato, G; Schroeder, FH1

Reviews

1 review(s) available for bromodeoxyuridine and Cancer of Prostate

ArticleYear
Recent advances in radiotherapy.
    Revista interamericana de radiologia, 1977, Volume: 2, Issue:3

    Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoid Tumor; Elementary Particles; Fast Neutrons; Hot Temperature; Humans; Male; Melanoma; Metronidazole; Neoplasms; Nitroimidazoles; Pancreatic Neoplasms; Prostatic Neoplasms; Protons; Radiation Protection; Radiation Tolerance; Radiation-Sensitizing Agents; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Soft Tissue Neoplasms

1977

Trials

1 trial(s) available for bromodeoxyuridine and Cancer of Prostate

ArticleYear
Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study.
    Prostate cancer and prostatic diseases, 2006, Volume: 9, Issue:4

    Topics: Aged; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Bromodeoxyuridine; Carotenoids; Disease Progression; DNA, Neoplasm; Dose-Response Relationship, Drug; Epithelial Cells; Follow-Up Studies; Humans; Lycopene; Male; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Regression Analysis; Treatment Outcome

2006

Other Studies

61 other study(ies) available for bromodeoxyuridine and Cancer of Prostate

ArticleYear
Protease-activated receptor-2 dependent and independent responses of bone cells to prostate cancer cell secretory products.
    The Prostate, 2022, Volume: 82, Issue:6

    Topics: Alkaline Phosphatase; Animals; Bone Neoplasms; Bromodeoxyuridine; Cell Differentiation; Cell Line, Tumor; Humans; Male; Mice; Osteoblasts; Osteoclasts; Prostatic Neoplasms; Receptor, PAR-2; Receptors, Proteinase-Activated

2022
Rat prostate tumors induce DNA synthesis in remote organs.
    Scientific reports, 2022, 05-12, Volume: 12, Issue:1

    Topics: Animals; Bromodeoxyuridine; DNA; Humans; Lymph Nodes; Male; Prostate; Prostatic Neoplasms; Rats

2022
Attenuation of nucleoside and anti-cancer nucleoside analog drug uptake in prostate cancer cells by Cimicifuga racemosa extract BNO-1055.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2013, Nov-15, Volume: 20, Issue:14

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Bromodeoxyuridine; Cell Line; Cell Proliferation; Cimicifuga; Deoxycytidine; Dose-Response Relationship, Drug; Equilibrative Nucleoside Transport Proteins; Fluorouracil; Gemcitabine; Humans; Male; Nucleosides; Phytotherapy; Plant Extracts; Prostate; Prostatic Neoplasms; RNA, Small Interfering; Saponins; Thymidine; Vidarabine

2013
Diosmin induces genotoxicity and apoptosis in DU145 prostate cancer cell line.
    Toxicology in vitro : an international journal published in association with BIBRA, 2015, Volume: 29, Issue:3

    Topics: Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Comet Assay; Diosmin; DNA Methylation; Humans; Male; Membrane Potential, Mitochondrial; Micronucleus Tests; Mutagens; Oxidative Stress; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles

2015
Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells.
    Cellular and molecular life sciences : CMLS, 2015, Volume: 72, Issue:17

    Topics: Analysis of Variance; Blotting, Western; Bromodeoxyuridine; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dinoprostone; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Microscopy, Fluorescence; Neovascularization, Pathologic; Phenotype; Prostatic Neoplasms; Receptors, Prostaglandin E, EP2 Subtype; Signal Transduction; Tetrazolium Salts; Thiazoles

2015
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
    Journal of the National Cancer Institute, 2009, Apr-01, Volume: 101, Issue:7

    Topics: Adenocarcinoma; Animals; Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Disease Models, Animal; Fatty Acid Synthase, Type I; Flow Cytometry; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunoblotting; Immunohistochemistry; Male; Mice; Mice, Transgenic; Oncogenes; Orchiectomy; Prostatic Neoplasms; RNA, Small Interfering; Transplantation, Heterologous; Up-Regulation

2009
Small interfering RNA-directed knockdown of uracil DNA glycosylase induces apoptosis and sensitizes human prostate cancer cells to genotoxic stress.
    Molecular cancer research : MCR, 2009, Volume: 7, Issue:8

    Topics: Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; DNA Damage; Doxorubicin; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Hydrogen Peroxide; Male; Prostatic Neoplasms; RNA Interference; RNA, Small Interfering; Tumor Suppressor Protein p53; Uracil; Uracil-DNA Glycosidase

2009
Preferential colonization of metastases by oncolytic vaccinia virus strain GLV-1h68 in a human PC-3 prostate cancer model in nude mice.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Animals; Biomarkers, Tumor; Bromodeoxyuridine; Cell Line, Tumor; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Lymphatic Metastasis; Macrophages; Male; Mice; Microscopy, Fluorescence; Neoplasm Metastasis; Neoplasm Transplantation; Oncolytic Viruses; Prostatic Neoplasms; Vaccinia virus

2012
Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
    The Prostate, 2002, Nov-01, Volume: 53, Issue:3

    Topics: Animals; Annexin A5; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Division; Coloring Agents; DNA Damage; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Male; Propidium; Prostatic Neoplasms; Rats; Silybin; Silymarin; Trypan Blue; Tumor Cells, Cultured

2002
The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells.
    Molecular cancer therapeutics, 2002, Volume: 1, Issue:7

    Topics: Adenocarcinoma; Benzhydryl Compounds; Bromodeoxyuridine; Cell Division; Cell Nucleus; Dihydrotestosterone; Dose-Response Relationship, Drug; Estrogens, Non-Steroidal; Flow Cytometry; Genes, Reporter; Humans; Immunoblotting; Kinetics; Male; Phenols; Plasmids; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Tumor Cells, Cultured

2002
Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array.
    Cancer research, 2003, Jan-01, Volume: 63, Issue:1

    Topics: Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Division; Humans; Kinetics; Male; Oligonucleotide Array Sequence Analysis; Organoselenium Compounds; Prostatic Neoplasms; Time Factors; Tumor Cells, Cultured

2003
Cdc37 enhances proliferation and is necessary for normal human prostate epithelial cell survival.
    Cancer research, 2003, Aug-01, Volume: 63, Issue:15

    Topics: Apoptosis; Bromodeoxyuridine; Cell Cycle Proteins; Cell Division; Cell Survival; Chaperonins; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Disease Progression; Drosophila Proteins; Enzyme Activation; Epithelial Cells; Humans; Male; Molecular Chaperones; Prostate; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf

2003
Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s).
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Aug-15, Volume: 9, Issue:9

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Bromodeoxyuridine; Carcinogens; Celecoxib; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Coloring Agents; Cyclin D; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cyclooxygenase 2; DNA; Dose-Response Relationship, Drug; Down-Regulation; Flow Cytometry; Immunohistochemistry; Isoenzymes; Male; Methylnitrosourea; Microscopy, Fluorescence; Models, Biological; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Pyrazoles; Rats; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Time Factors; Tumor Suppressor Proteins

2003
G3139 (oblimersen) may inhibit prostate cancer cell growth in a partially bis-CpG-dependent non-antisense manner.
    Molecular cancer therapeutics, 2003, Volume: 2, Issue:10

    Topics: Agar; Amino Acid Motifs; Annexin A5; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Membrane; Coloring Agents; CpG Islands; DNA; DNA Methylation; Down-Regulation; Enzyme Inhibitors; Flow Cytometry; G1 Phase; Guanosine; Humans; Male; Membrane Potentials; Mitochondria; Mutation; Oligonucleotides; Oligonucleotides, Antisense; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Reactive Oxygen Species; S Phase; Thionucleotides; Time Factors; Transfection

2003
Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest.
    Carcinogenesis, 2004, Volume: 25, Issue:8

    Topics: Acetylcysteine; Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cell Separation; Coloring Agents; Cyclin D; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Flow Cytometry; G1 Phase; Humans; Isothiocyanates; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitosis; Neoplasm Transplantation; Neoplasms; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; S Phase; Time Factors; Tumor Suppressor Proteins; Up-Regulation; Vegetables

2004
Exposure to continuous bromodeoxyuridine (BrdU) differentially affects cell cycle progression of human breast and bladder cancer cell lines.
    Cell proliferation, 2004, Volume: 37, Issue:2

    Topics: Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Survival; Cytogenetic Analysis; DNA; DNA Replication; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Male; Prostatic Neoplasms; Reproducibility of Results

2004
The novel estrogen 17alpha-20Z-21-[(4-amino)phenyl]-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diol induces apoptosis in prostate cancer cell lines at nanomolar concentrations in vitro.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:5

    Topics: Apoptosis; Blotting, Western; Bromodeoxyuridine; Caspase 3; Caspases; Cell Cycle; Cell Line, Tumor; Drug Screening Assays, Antitumor; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Flow Cytometry; Humans; Male; Models, Molecular; Prostatic Neoplasms; Protein Binding

2004
In vitro combination treatment with perifosine and UCN-01 demonstrates synergism against prostate (PC-3) and lung (A549) epithelial adenocarcinoma cell lines.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Aug-01, Volume: 10, Issue:15

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Female; Humans; Immunoblotting; Lung Neoplasms; Male; Phosphorylcholine; Prostatic Neoplasms; Signal Transduction; Staurosporine; Time Factors

2004
Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells.
    Experimental biology and medicine (Maywood, N.J.), 2005, Volume: 230, Issue:3

    Topics: Anticarcinogenic Agents; Apoptosis; Bromodeoxyuridine; Carotenoids; Cell Proliferation; Cytochrome c Group; Dose-Response Relationship, Drug; Humans; L-Lactate Dehydrogenase; Lycopene; Male; Membrane Potentials; Mitochondria; Prostatic Neoplasms; Tumor Cells, Cultured

2005
Dependence of FDG uptake on tumor microenvironment.
    International journal of radiation oncology, biology, physics, 2005, Jun-01, Volume: 62, Issue:2

    Topics: Animals; Autoradiography; Benzimidazoles; Bromodeoxyuridine; Cell Hypoxia; Cell Proliferation; Coloring Agents; Fluorodeoxyglucose F18; Glucose; Male; Mice; Mice, Nude; Neoplasms; Nitroimidazoles; Prostatic Neoplasms; Radiopharmaceuticals

2005
Selenium- or quercetin-induced retardation of DNA synthesis in primary prostate cells occurs in the presence of a concomitant reduction in androgen-receptor activity.
    Cancer letters, 2006, Jul-28, Volume: 239, Issue:1

    Topics: Androgen Receptor Antagonists; Antioxidants; Bromodeoxyuridine; DNA Replication; DNA, Neoplasm; Epithelial Cells; Humans; Male; Prostate; Prostatic Neoplasms; Quercetin; Receptors, Androgen; Selenium; Tumor Cells, Cultured

2006
Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Jan-31, Volume: 103, Issue:5

    Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Separation; Disease Models, Animal; Disease Progression; DNA-Binding Proteins; Flow Cytometry; Gene Deletion; Genes, Tumor Suppressor; Humans; Immunohistochemistry; Ki-67 Antigen; Kinetics; Male; Mice; Mice, Knockout; Microscopy, Fluorescence; Neoplasms; Phosphoproteins; Prostatic Neoplasms; PTEN Phosphohydrolase; Stem Cells; Time Factors; Trans-Activators; Transcription Factors; Tumor Suppressor Proteins

2006
The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine.
    Cell biology and toxicology, 2006, Volume: 22, Issue:6

    Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Benzophenanthridines; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Survival; Comet Assay; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fibroblasts; Formazans; Gingiva; Humans; In Situ Nick-End Labeling; Isoquinolines; Male; Prostatic Neoplasms; Tetrazolium Salts

2006
Anti-prostate cancer activity of a beta-carboline alkaloid enriched extract from Rauwolfia vomitoria.
    International journal of oncology, 2006, Volume: 29, Issue:5

    Topics: Alkaloids; Animals; Apoptosis; Biological Assay; Bromodeoxyuridine; Carbolines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA; DNA Damage; Gene Expression; Humans; Male; Mice; Mice, Nude; Plant Extracts; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Rauwolfia; Xenograft Model Antitumor Assays

2006
Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
    Cancer research, 2007, Jul-01, Volume: 67, Issue:13

    Topics: Androgens; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Male; Prostatic Neoplasms; Receptors, Androgen; Retinoblastoma Protein; Time Factors; Transfection

2007
Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density.
    International journal of cancer, 2008, Jan-01, Volume: 122, Issue:1

    Topics: Animals; Apoptosis; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; G1 Phase; Humans; Immunoblotting; Immunoprecipitation; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Oncogene Proteins; Organoselenium Compounds; Prostatic Neoplasms; Retinoblastoma Protein; S Phase

2008
p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:10

    Topics: Antioxidants; Blotting, Western; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; G1 Phase; Humans; Immunoprecipitation; Luciferases; Male; Phosphorylation; Promoter Regions, Genetic; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; S-Phase Kinase-Associated Proteins; Silybin; Silybum marianum; Silymarin

2007
Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.
    Neoplasia (New York, N.Y.), 2007, Volume: 9, Issue:11

    Topics: Adenocarcinoma; Androgens; Animals; Antigens, Polyomavirus Transforming; Apoptosis; Bromodeoxyuridine; Cell Proliferation; Disease Models, Animal; Hepatocyte Nuclear Factor 3-beta; Lymphatic Metastasis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Simian virus 40; Synaptophysin

2007
Kruppel-like factor 4 is a novel mediator of selenium in growth inhibition.
    Molecular cancer research : MCR, 2008, Volume: 6, Issue:2

    Topics: Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Organoselenium Compounds; Prostatic Neoplasms; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA Stability; RNA, Messenger; RNA, Small Interfering; Selenium; Transcription, Genetic; Up-Regulation

2008
Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-1 in formalin-fixed, paraffin-embedded prostatic cancer tissues.
    The Prostate, 1995, Volume: 27, Issue:3

    Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Division; Formaldehyde; Frozen Sections; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Neoplasm Transplantation; Nuclear Proteins; Paraffin Embedding; Prostatectomy; Prostatic Neoplasms; Tissue Fixation; Tumor Cells, Cultured

1995
A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal.
    Cancer research, 1993, Oct-01, Volume: 53, Issue:19

    Topics: Adenocarcinoma; Androgens; Animals; Blotting, Western; Bromodeoxyuridine; Cell Division; Humans; Immunohistochemistry; Male; Molecular Weight; Nuclear Proteins; Orchiectomy; Phosphoproteins; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Regeneration; RNA, Messenger; Seminal Vesicles; Time Factors

1993
Proliferative activity in benign and neoplastic prostatic epithelium.
    The Journal of pathology, 1994, Volume: 174, Issue:3

    Topics: Bromodeoxyuridine; Cell Division; Epithelium; Humans; Male; Neoplasm Staging; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Diseases; Prostatic Neoplasms

1994
Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
    The Prostate, 1995, Volume: 26, Issue:2

    Topics: Adenocarcinoma; Antibodies, Monoclonal; Biomarkers, Tumor; Biopsy, Needle; Bromodeoxyuridine; Cell Division; Humans; Immunoglobulin M; Immunohistochemistry; Ki-67 Antigen; Male; Mitotic Index; Neoplasm Proteins; Neoplasm Staging; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Prostatectomy; Prostatic Neoplasms; T-Lymphocytes

1995
Influence of sampling time on assessment of potential doubling time.
    Cytometry, 1994, Jun-01, Volume: 16, Issue:2

    Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Rats, Inbred F344; Reproducibility of Results; S Phase; Specimen Handling; Time Factors

1994
Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression.
    The Journal of urology, 1993, Volume: 149, Issue:2

    Topics: Adenocarcinoma; Antigens, Neoplasm; Bromodeoxyuridine; Cell Division; Humans; Male; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Prospective Studies; Prostatic Neoplasms; Random Allocation; Tumor Cells, Cultured

1993
Measurement of the proliferative activity of three different sublines of the Dunning rat prostate tumor R3327.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1993, Volume: 169, Issue:7

    Topics: Animals; Bromodeoxyuridine; Carcinoma; Cell Division; DNA, Neoplasm; Flow Cytometry; Immunohistochemistry; Male; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Time Factors; Tumor Cells, Cultured

1993
Ki-67 expression and BrdUrd incorporation as markers of proliferative activity in human prostate tumour models.
    Cell proliferation, 1993, Volume: 26, Issue:1

    Topics: Animals; Biomarkers, Tumor; Bromodeoxyuridine; Cell Division; Dihydrotestosterone; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Male; Mice; Models, Biological; Neoplasm Proteins; Nuclear Proteins; Prostatic Neoplasms; Testosterone; Tumor Cells, Cultured

1993
The effect of castration on tumor growth rate and cell kinetics in hormone sensitive and hormone insensitive rat prostatic adenocarcinomas.
    Scandinavian journal of urology and nephrology. Supplementum, 1995, Volume: 172

    Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Cycle; Flow Cytometry; Male; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Tumor Cells, Cultured

1995
Nuclear protein as a prognostic factor of growth activity in prostatic adenocarcinoma.
    Urological research, 1996, Volume: 24, Issue:5

    Topics: Adenocarcinoma; Androgens; Animals; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Humans; Male; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Nuclear Proteins; Orchiectomy; Prognosis; Prostatic Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured

1996
Growth characteristics in the initial stage of micrometastasis formation by bacterial LacZ gene-tagged rat prostatic adenocarcinoma cells.
    Japanese journal of cancer research : Gann, 1996, Volume: 87, Issue:12

    Topics: Adenocarcinoma; Animals; beta-Galactosidase; Bromodeoxyuridine; Cell Division; Collagen; Disease Models, Animal; Galactosides; Genes, Bacterial; Indoles; Kinetics; Lac Operon; Male; Mice; Mice, Nude; Microscopy, Electron; Neoplasm Metastasis; Prostatic Neoplasms; Rats

1996
Muscarinic cholinergic receptors promote growth of human prostate cancer cells.
    The Prostate, 1997, Feb-15, Volume: 30, Issue:3

    Topics: Bromodeoxyuridine; Carbachol; DNA, Neoplasm; Humans; Immunohistochemistry; Male; Prostatic Neoplasms; Receptors, Muscarinic; Thymidine; Tumor Cells, Cultured; Up-Regulation

1997
Decrease of prostaglandin E2 and 5-bromo-2'-deoxyuridine labeling but not prostate tumor development by indomethacin treatment of rats given 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate.
    Japanese journal of cancer research : Gann, 1997, Volume: 88, Issue:4

    Topics: Aminobiphenyl Compounds; Animals; Body Weight; Bromodeoxyuridine; Dinoprostone; DNA; Indomethacin; Male; Organ Size; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred F344; Seminal Vesicles; Testosterone

1997
Growth of human prostate carcinomas with and without hormone alpha- dehydrotestosterone in nude mice.
    European urology, 1998, Volume: 34, Issue:6

    Topics: Animals; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Cell Division; Disease Progression; DNA, Neoplasm; Drug Implants; Flow Cytometry; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Testosterone; Transplantation, Heterologous; Tumor Cells, Cultured

1998
Morphometric analysis of bromodeoxyuridine distribution and cell density in the rat Dunning prostate tumor R3327-AT1 following treatment with radiation and/or hyperthermia.
    Histology and histopathology, 1999, Volume: 14, Issue:2

    Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Count; Fever; Male; Prostatic Neoplasms; Rats; Tumor Cells, Cultured

1999
Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1999, Volume: 10, Issue:4

    Topics: Adenoviridae; Apoptosis; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kinetics; Luciferases; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; S Phase; Tetradecanoylphorbol Acetate; Thymidine; Time Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured

1999
Growth and characterization of LNCaP prostate cancer cell spheroids.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:10 Suppl

    Topics: Bromodeoxyuridine; Cell Division; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Spheroids, Cellular; Tumor Cells, Cultured

1999
Analysis of oxidative DNA damage and HPRT mutant frequencies in cancer patients before and after radiotherapy.
    Mutation research, 1999, Dec-17, Volume: 431, Issue:2

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Aged, 80 and over; Antioxidants; Biomarkers; Breast Neoplasms; Bromodeoxyuridine; Deoxyguanosine; DNA Damage; Female; Head and Neck Neoplasms; Humans; Hypoxanthine Phosphoribosyltransferase; Male; Micronucleus Tests; Middle Aged; Neoplasms; Oxidation-Reduction; Prostatic Neoplasms; Smoking

1999
Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 2000, Volume: 11, Issue:7

    Topics: Adenocarcinoma; Androgens; Animals; Bromodeoxyuridine; CDC2-CDC28 Kinases; Cell Cycle; Cell Line; Culture Media; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Cyclins; Electrophoresis, Polyacrylamide Gel; Fibroblasts; Genetic Vectors; Humans; Immunoblotting; Male; Neoplasms, Hormone-Dependent; Phosphorylation; Plasmids; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; ras Proteins; Rats; Retinoblastoma Protein; Signal Transduction; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2000
Simultaneous estimation of T(G2+M), T(S), and T(pot) using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry.
    Cytometry, 2000, Sep-01, Volume: 41, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Bromodeoxyuridine; DNA, Neoplasm; Female; Flow Cytometry; G2 Phase; Halogens; Interphase; Kinetics; Male; Mammary Neoplasms, Experimental; Mice; Mitosis; Orchiectomy; Paclitaxel; Prostatic Neoplasms; Rats; S Phase; Thymidine

2000
Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
    Molecular and cellular biology, 2001, Volume: 21, Issue:24

    Topics: Androgens; Bombesin; Bromodeoxyuridine; Cell Division; Enzyme Activation; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Genes, Dominant; Genes, Reporter; Humans; Luciferases; Male; Models, Biological; Neuropeptides; Plasmids; Precipitin Tests; Prostatic Neoplasms; Protein Binding; Protein-Tyrosine Kinases; Signal Transduction; src-Family Kinases; Time Factors; Transcriptional Activation; Transfection; Tumor Cells, Cultured

2001
Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.
    Molecular and cellular biology, 2001, Volume: 21, Issue:24

    Topics: Bromodeoxyuridine; Butadienes; Cell Differentiation; Cell Division; Chloramphenicol O-Acetyltransferase; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Epinephrine; Humans; Immunoblotting; Immunoenzyme Techniques; Interleukin-6; Male; MAP Kinase Signaling System; Mitosis; Nitriles; Phenotype; Prostatic Neoplasms; Proto-Oncogene Proteins c-fos; Ribonucleases; Signal Transduction; STAT3 Transcription Factor; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured

2001
Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:6

    Topics: Adenocarcinoma; Adenoviridae; Animals; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Division; Genes, Tumor Suppressor; Genetic Therapy; Humans; In Situ Nick-End Labeling; Lymphatic Metastasis; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phosphoric Monoester Hydrolases; Prostatic Neoplasms; PTEN Phosphohydrolase; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2002
Effect of bromodeoxyuridine and interferon on cellular and viral functions in human prostatic cells.
    Oncology, 1979, Volume: 36, Issue:1

    Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Line; DNA, Viral; Humans; Inclusion Bodies, Viral; Interferons; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Retroviridae

1979
Effects of adrenal androgens on the transplantable human prostate tumor PC-82.
    Endocrinology, 1992, Volume: 131, Issue:6

    Topics: Androstenedione; Animals; Bromodeoxyuridine; Cell Division; Dehydroepiandrosterone; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Orchiectomy; Prostatic Neoplasms; Testosterone; Tumor Cells, Cultured

1992
Regulation of androgen receptor expression in the human heterotransplantable prostate carcinoma PC-82.
    Endocrinology, 1992, Volume: 131, Issue:6

    Topics: Androgens; Animals; Base Sequence; Blotting, Western; Bromodeoxyuridine; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Immunohistochemistry; Male; Mice; Mice, Nude; Molecular Sequence Data; Neoplasm Transplantation; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Single-Strand Specific DNA and RNA Endonucleases; Tumor Cells, Cultured

1992
Role of the vertebral venous system in metastatic spread of cancer cells to the bone.
    Advances in experimental medicine and biology, 1992, Volume: 324

    Topics: Adenocarcinoma; Animals; Bone Marrow; Bone Neoplasms; Bromodeoxyuridine; Constriction; Epidural Space; Humans; Incidence; Lung; Male; Mice; Mice, Inbred C3H; Mice, Inbred ICR; Mice, Nude; Neoplasm Transplantation; Neoplastic Cells, Circulating; Osteosarcoma; Prostatic Neoplasms; Spine; Tail; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Veins; Vena Cava, Inferior

1992
Measurement of in vivo urological tumour cell kinetics using multiparameter flow cytometry. Preliminary study.
    British journal of urology, 1991, Volume: 68, Issue:1

    Topics: Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; DNA, Neoplasm; Flow Cytometry; Humans; Kidney Neoplasms; Kinetics; Male; Mitosis; Penile Neoplasms; Prostatic Neoplasms; S Phase; Urinary Bladder Neoplasms

1991
Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies.
    The Journal of urology, 1991, Volume: 146, Issue:4

    Topics: Aged; Aged, 80 and over; Biopsy, Needle; Bromodeoxyuridine; Carcinoma; Cell Division; DNA, Neoplasm; Flow Cytometry; Humans; Male; Middle Aged; Ploidies; Prostatic Neoplasms; S Phase

1991
S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling.
    Cancer, 1990, Aug-01, Volume: 66, Issue:3

    Topics: Adenocarcinoma; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; Humans; Immunoenzyme Techniques; Male; Prognosis; Prostatic Neoplasms

1990
Immunocytochemical demonstration of S phase cells by anti-bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma.
    The Journal of urology, 1989, Volume: 141, Issue:2

    Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Humans; Immunoenzyme Techniques; Interphase; Male; Middle Aged; Prostate; Prostatic Neoplasms

1989
Human prostatic adenocarcinoma: growth in monolayer tissue culture.
    The Journal of urology, 1971, Volume: 106, Issue:5

    Topics: Acid Phosphatase; Adenocarcinoma; Androgens; Animals; Bromodeoxyuridine; Cell Division; Culture Media; Culture Techniques; DNA, Neoplasm; Dogs; Epithelium; Fibroblasts; Humans; Light; Male; Microscopy, Phase-Contrast; Prostatic Neoplasms; Zinc

1971